MoneyWorks4Me

Tyche Inds - Quaterly Results

10 Aug 2024 Evaluate
The sales slipped to Rs. 155.20 millions for the June 2024 quarter as against Rs. 170.51 millions during the year-ago period.A meek growth of 0.48% was reported for the quarter ended June 2024 to Rs. 27.27  millions from Rs. 27.14 millions.Operating profit surged to 41.38 millions from the corresponding previous quarter of 40.89 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202406 202306 % Var 202406 202306 % Var 202403 202303 % Var
Sales 155.20 170.51 -8.98 155.20 170.51 -8.98 695.10 753.85 -7.79
Other Income 15.25 12.91 18.13 15.25 12.91 18.13 59.24 48.28 22.70
PBIDT 41.38 40.89 1.20 41.38 40.89 1.20 185.70 209.78 -11.48
Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.02 0.01 100.00
PBDT 41.38 40.89 1.20 41.38 40.89 1.20 185.68 208.57 -10.97
Depreciation 4.94 4.58 7.86 4.94 4.58 7.86 19.41 17.73 9.48
PBT 36.44 36.31 0.36 36.44 36.31 0.36 166.27 190.84 -12.87
TAX 9.17 9.17 0.00 9.17 9.17 0.00 43.86 49.12 -10.71
Deferred Tax -0.26 -0.27 -3.70 -0.26 -0.27 -3.70 -0.73 -1.20 -39.17
PAT 27.27 27.14 0.48 27.27 27.14 0.48 122.41 141.72 -13.63
Equity 102.45 102.45 0.00 102.45 102.45 0.00 102.45 102.45 0.00
PBIDTM(%) 26.66 23.98 11.18 26.66 23.98 11.18 26.72 27.83 -4.00
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..